249 related articles for article (PubMed ID: 20429876)
1. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth.
Yallapu MM; Maher DM; Sundram V; Bell MC; Jaggi M; Chauhan SC
J Ovarian Res; 2010 Apr; 3():11. PubMed ID: 20429876
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.
Yallapu MM; Khan S; Maher DM; Ebeling MC; Sundram V; Chauhan N; Ganju A; Balakrishna S; Gupta BK; Zafar N; Jaggi M; Chauhan SC
Biomaterials; 2014 Oct; 35(30):8635-48. PubMed ID: 25028336
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
4. Curcumin Nanoformulation for Cervical Cancer Treatment.
Zaman MS; Chauhan N; Yallapu MM; Gara RK; Maher DM; Kumari S; Sikander M; Khan S; Zafar N; Jaggi M; Chauhan SC
Sci Rep; 2016 Feb; 6():20051. PubMed ID: 26837852
[TBL] [Abstract][Full Text] [Related]
5. Alkaloids from Stephania venosa as Chemo-Sensitizers in SKOV3 Ovarian Cancer Cells via Akt/NF-κB Signaling.
Mon MT; Yodkeeree S; Punfa W; Pompimon W; Limtrakul P
Chem Pharm Bull (Tokyo); 2018; 66(2):162-169. PubMed ID: 29386467
[TBL] [Abstract][Full Text] [Related]
6. A Co-Delivery System of Curcumin and p53 for Enhancing the Sensitivity of Drug-Resistant Ovarian Cancer Cells to Cisplatin.
Guo X; Fang Z; Zhang M; Yang D; Wang S; Liu K
Molecules; 2020 Jun; 25(11):. PubMed ID: 32512936
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
[TBL] [Abstract][Full Text] [Related]
8. Honokiol combined with curcumin sensitizes multidrug-resistant human lung adenocarcinoma A549/DDP cells to cisplatin.
Qi M; Chen X; Bian L; Zhang H; Ma J
Exp Ther Med; 2021 Nov; 22(5):1301. PubMed ID: 34630656
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional PEGylated Niosomal Nanoparticle-Loaded Herbal Drugs as a Novel Nano-Radiosensitizer and Stimuli-Sensitive Nanocarrier for Synergistic Cancer Therapy.
Afereydoon S; Haghiralsadat F; Hamzian N; Shams A; Hemati M; Naghib SM; Shabani M; Zandieh-Doulabi B; Tofighi D
Front Bioeng Biotechnol; 2022; 10():917368. PubMed ID: 36046674
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of 'hypoxic' breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling.
Aravindan S; Natarajan M; Herman TS; Awasthi V; Aravindan N
Radiat Oncol; 2013 Mar; 8():46. PubMed ID: 23452621
[TBL] [Abstract][Full Text] [Related]
11. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer's disease.
Fan S; Zheng Y; Liu X; Fang W; Chen X; Liao W; Jing X; Lei M; Tao E; Ma Q; Zhang X; Guo R; Liu J
Drug Deliv; 2018 Nov; 25(1):1091-1102. PubMed ID: 30107760
[TBL] [Abstract][Full Text] [Related]
13. Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A).
Khan MN; Haggag YA; Lane ME; McCarron PA; Tambuwala MM
Curr Drug Deliv; 2018 Feb; 15(2):286-295. PubMed ID: 29065834
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells.
Chang PY; Peng SF; Lee CY; Lu CC; Tsai SC; Shieh TM; Wu TS; Tu MG; Chen MY; Yang JS
Int J Oncol; 2013 Oct; 43(4):1141-50. PubMed ID: 23917396
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells.
Liu Z; Zhu YY; Li ZY; Ning SQ
Oncol Lett; 2016 Nov; 12(5):3944-3948. PubMed ID: 27895754
[TBL] [Abstract][Full Text] [Related]
16. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line.
Doggui S; Sahni JK; Arseneault M; Dao L; Ramassamy C
J Alzheimers Dis; 2012; 30(2):377-92. PubMed ID: 22426019
[TBL] [Abstract][Full Text] [Related]
17. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species.
Sankpal UT; Nagaraju GP; Gottipolu SR; Hurtado M; Jordan CG; Simecka JW; Shoji M; El-Rayes B; Basha R
Oncotarget; 2016 Jan; 7(3):3186-200. PubMed ID: 26672603
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
[TBL] [Abstract][Full Text] [Related]
19. Photoprotective efficiency of PLGA-curcumin nanoparticles versus curcumin through the involvement of ERK/AKT pathway under ambient UV-R exposure in HaCaT cell line.
Chopra D; Ray L; Dwivedi A; Tiwari SK; Singh J; Singh KP; Kushwaha HN; Jahan S; Pandey A; Gupta SK; Chaturvedi RK; Pant AB; Ray RS; Gupta KC
Biomaterials; 2016 Apr; 84():25-41. PubMed ID: 26803409
[TBL] [Abstract][Full Text] [Related]
20. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
